Compare Enveric Biosciences Inc (ENVB) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Open Text Corporation — how do they compare? Enveric Biosciences Inc trades at $1.36 (market cap $5.32M), while Open Text Corporation trades at $23.2 (market cap $5.45B). The key difference: Open Text Corporation is far larger — about 1024.4× Enveric Biosciences Inc's market cap, and Open Text Corporation pays a 4.84% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | OTEX | |
|---|---|---|
Market Cap | $5.32M | $5.45B |
Sector | Health | Technology |
52-Week High | $17.40 | $39.69 |
52-Week Low | $1.28 | $20.01 |
Enterprise Value | $408.82K | $10.61B |
Dividend Yield | — | 4.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
OpenText (OTEX) trades at $22.76, showing modest daily gains. The stock presents a mixed picture: technical indicators are bearish, but fundamental valuation metrics appear attractive with a P/E of 11.04 and EV/EBITDA of 6.63. The company has consistently beaten earnings expectations in recent quarters and is executing a strategic shift, divesting non-core assets like Vertica while investing in AI and cloud capabilities in Europe. Operating cash flow remains strong at $831M for 2025.
The outlook is cautiously optimistic. The primary opportunity lies in the stock's apparent undervaluation relative to its cash flow and the strategic repositioning towards high-growth AI and cloud segments. Key risks include execution of the new CEO's organic growth plan, competitive pressures in enterprise software, and the stock's current bearish technical momentum which may persist in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
